ЖурналыПодпискаАрхивКнигиПроектыО насРекламаДоставка/ОплатаКонтакты
+7 (495) 482-43-29
  • Главная
  • / Журналы
  • / Вернуться в журнал
  • / Содержание номера
  • / Статья
STW-5. Девять трав здоровья

STW-5. Девять трав здоровья

Авторы:
Лаура Зелимхановна Болиева

Журнал: Non nocere. Новый терапевтический журнал. 2026;(9):100-109.

Прочитано: 73 раза

Резюме

Современные представления о фармакологических механизмах действия комбинированных растительных средств при функциональных заболеваниях желудочно-кишечного тракта.

Дата публикации: 13.10.2026

Литература / References
  1. Petrovska BB. Historical review of medicinal plants’ usage. Pharmacogn Rev. 2012;6(11):1-5. https://doi.org/10.4103/0973-7847.95849
  2. Pirintsos S, Panagiotopoulos A, Bariotakis M. et al. From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples. Molecules. 2022;27(13)0460. https://doi.org/10.3390/molecules27134060
  3. Куркин В.А., Авдеева Е.В., Куркина А.В. и др. Современная фитотерапия как наука и учебная дисциплина в медицинском и фармацевтическом образовании. Медицинский вестник Башкортостана. 2016;5(65):149-52.
  4. Инструкция по медицинскому применению лекарственного препарата Иберогаст® [Электронный ресурс] // Государственный реестр лекарственных средств. – 2026. (дата обращения: 03.08.2026) https://grls.minzdrav.gov.ru/InstrImg/2024/09/06/1508438/9bff09a7-7517-4495-8d93-887ab56f18a5.pdf
  5. Калинкина Г.И. Основы фитотерапии : учебное пособие / Г.И. Калинкина, Н.Э. Коломиец. – Томск : СибГМУ, 2014. – 84 с.
  6. Kroll U, Cordes C. Pharmaceutical prerequisites for a multi-target therapy. Phytomedicine. 2006;13:12-19. https://doi.org/10.1016/j.phymed.2006.03.016
  7. Abdel-Aziz H, Kelber O, Lorkowski G, Storr M. Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast. Planta Med. 2017;83(14-15):1130-1140. https://doi.org/10.1055/s-0043-116852
  8. Khayyal MT, Abdeltawab NF, El-Sayed S, Vinson B, Abdel-Aziz H. Effect of the herbal preparation STW 5 on the microbiome in an experimental model of functional dyspepsia [conference abstract]. Gastroenterology. 2017;152(5):S1009. https://doi.org/10.1016/S0016-5085(17)33423-6
  9. Moissl-Eichinger C, Koskinen K, Pferschy-Wenzig E-M, Rossmann A, Abdel-Aziz H, Bauer R. Interaction between the herbal preparation STW 5 and human intestinal bacteria in vitro [conference abstract]. Gastroenterology. 2017;152(5 Suppl. 1): S206. https://doi.org/10.1016/S0016-5085(17)30995-2
  10. Thumann TA, Pferschy-Wenzig E-M, Kumpitsch C, et al. Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donors. Microbiol Spectr. 2024;12(6):e0403123. https://doi.org/10.1128/spectrum.04031-23
  11. Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011;82(4):513-523. https://doi.org/10.1016/j.fitote.2011.01.018
  12. Зенков Н.К., Меньщикова Е.Б., Ткачев В.О. Редокс-чувствительная сигнальная система Keap1/Nrf2/ARE как фармакологическая мишень. Обзор. Биохимия. 2013;78(1):27-47.
  13. García-Lafuente A, Guillamón E, Villares A, Rostagno MA, Martínez JA. Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm Res. 2009;58(9):537-552. https://doi.org/10.1007/s00011-009-0037-3
  14. Chirumbolo S. The Role of Quercetin, Flavonols and Flavones in Modulating Inflammatory Cell Function. Inflammation & Allergy. Drug Targets. 2010;9(4):263-285. https://doi.org/10.2174/187152810793358741
  15. Garcia-Mediavilla V, Crespo I. Collado P, et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol. 2007;557(2-3):221-229. https://doi.org/10.1016/j.ejphar.2006.11.014
  16. Sibaev A, Yüce B, Kelber O, Storr M. Die exzitatorische, cholinerge und inhibitorische, purinerge Neurotransmission wird durch Kaempferol einem Flavonoid der Iberis amara im Colon von Nagern gehemmt. Z Gastroenterol. 2010;48:261. https://doi.org/10.1055/s-0030-1263701
  17. Sibaev A, Yüce B, Kelber O, Storr M. Kaempferol and Cucurbitacin E Cardinal Constituents of Iberis Amara Reduce Excitatory Cholinergic and Inhibitory Purinergic Neurotransmission in Rodents [conference abstract]. Gastroenterology. 2010;138(5 Suppl. 1):W1945. https://doi.org/10.1016/S0016-5085(10)63558-5
  18. Yang M, Xiao R, Yu W, et al. Kaempferol Inhibits Colonic Contractions via L-Type Voltage Dependent Calcium Channels in Murine Smooth Muscle Cells. ACS Omega 2025;10:55307-55315. https://doi.org/10.1021/acsomega.5c03615
  19. Herbrechter R, Ziemba PM, Hoffmann KM, Hatt H, Werner M, Gisselmann G. Identification of Glycyrrhiza as the rikkunshito constituent with the highest antagonistic potential on heterologously expressed 5-HT3A receptors due to the action of flavonoids. Front Pharmacol. 2015;6:130. https://doi.org/10.3389/fphar.2015.00130
  20. Ventura-Martinez R, Angeles-Lopez GE, Gonzalez-Trujano ME, Carrasco OF, Deciga-Campos M. Study of Antispasmodic and Antidiarrheal Activities of Tagetes lucida (Mexican Tarragon) in Experimental Models and Its Mechanism of Action. Evid Based Complement Alternat Med. 2020;1:7140642. https://doi.org/10.1155/2020/7140642
  21. Gowtham A, Mishra T, Gungha T, Kaundal RK. Scopoletin Mitigates DSS-Induced Ulcerative Colitis by Attenuating NF-κB/MMP-9 Mediated Inflammation and Activating the Nrf2 Pathway to Preserve Colonic Barrier Integrity. Drug Dev Res. 2025;86(7):e70165. https://doi.org/10.1002/ddr.70165
  22. Witaicenis A, Seito LN, da Silveira Chagas A, et al. Antioxidant and intestinal anti-inflammatory effects of plant-derived coumarin derivatives. Phytomedicine. 2014;21(3):240-246. https://doi.org/10.1016/j.phymed.2013.09.001
  23. Zhan F, Song W, Fan Y, Wang F, Wang Q. Cucurbitacin E Alleviates Colonic Barrier Function Impairment and Inflammation Response and Improves Microbial Composition on Experimental Colitis Models. J. Inflamm. Res. 2024;17:2745-2756. https://doi.org/10.2147/JIR.S456353
  24. Li J, Shen X, Wu X, et al. Cucurbitacin B alleviates DSS-induced ulcerative colitis by improving gut microbiota disorder in C57BL/6 mice. AMB Express. 2025;15:111-122. https://doi.org/10.1186/s13568-025-01922-5
  25. Bezerra JJL, da Silva MS, de Barros SCL, et al. Evaluation of the antiulcerogenic and antidiarrheal activities of essential oils from Croton jacobinensis Baill. (Euphorbiaceae) and its major compound α-pinene. Journal of Ethnopharmacology. 2026;369:121945. https://doi.org/10.1016/j.jep.2026.121945
  26. De Almeida PM, Magalhães RM, Torres DM, et al. Gastroprotective effect of alpha-pinene and its correlation with antiulcerogenic activity of essential oils obtained from Hyptis species. Pharmacogn Mag. 2015;11(41):123-130. https://doi.org/10.4103/0973-1296.149725
  27. Bezerra SB, Leal LK, Nogueira NA, Campos AR. Bisabolol-induced gastroprotection against acute gastric lesions: role of prostaglandins, nitric oxide, and KATP+ channels. J Med Food. 2009;12(6):1403-1406. https://doi.org/10.1089/jmf.2008.0290
  28. Rahimi K, Shirvani N, Sanaie P, Javadi A, Khademi M. The effects of alpha-pinene on the Nrf2-HO1 signaling pathway in gastric damage in rats. Mol Biol Rep. 2023;50(10):8615-8622. https://doi.org/10.1007/s11033-023-08765-y
  29. Alkanat M, Alkanat HÖ. Long‐Term Pretreatment With D‐Limonene Protects Gastric Lipid Composition by Reducing Oxidative Damage and Inflammation in Indomethacin‐Induced Gastric Injury. J Food Biochem. 2025;49(1):e6639397. https://doi.org/10.1155/jfbc/6639397
  30. Senthil Kumar KJ, Gokila Vani M, Dakpa G, Wang SY. Dietary limonene promotes gastrointestinal barrier function via upregulating tight/adherens junction proteins through cannabinoid receptor type-1 antagonistic mechanism and alters cellular metabolism in intestinal epithelial cells. BioFactors. 2025;51(1):e2106. https://doi.org/10.1002/biof.2106
  31. Riyazi A, Hensel A, Bauer K, Geissler N, Schaaf S, Verspohl EJ. The effect of the volatile oil from ginger rhizomes (Zingiber officinale), its fractions and isolated compounds on the 5-HT3 receptor complex and the serotoninergic system of the rat ileum. Planta Med. 2007;73(4):355-362. https://doi.org/10.1055/s-2007-967171
  32. Devi RC, Sim SM, Ismail R. Spasmolytic effect of citral and extracts of Cymbopogon citratus on isolated rabbit ileum. J Smooth Muscle Res. 2011;47(5):143-156. https://doi.org/10.1540/jsmr.47.143
  33. Silva CMS, Wanderley CWS, Lima-Junior FJB, et al. Carvone (R)-(–) and (S)-(+) enantiomers inhibits upper gastrointestinal motility in mice. Flavour Fragr. J. 2015;30:439-444. https://doi.org/10.1002/ffj.3267
  34. Krueger D, Schäuffele S, Zeller F, et al. Peppermint and caraway oils have muscle inhibitory and pro secretory activity in the human intestine in vitro. Neurogastroenterol Motil. 2020;32:e13748. https://doi.org/10.1111/nmo.13748
  35. Jael Teresa de Jesús QV, Gálvez-Ruíz JC, Márquez Ibarra AA, Leyva-Peralta MA. Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent. Pharmaceuticals (Basel). 2025;18(2):193-212. https://doi.org/10.3390/ph18020193
  36. Hiller KO, Ghorbani M, Schilcher H. Antispasmodic and relaxant activity of chelidonine, protopine, coptisine, and Chelidonium majus extracts on isolated guinea-pig ileum. Planta Med. 1998;64(8):758-760. https://doi.org/10.1055/s-2006-957576
  37. Nozawa K, Kawabata-Shoda E, Doihara H, et al. TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci USA. 2009;106(9):3408-3413. https://doi.org/10.1073/pnas.0805323106
  38. Fothergill LJ, Callaghan B, Rivera LR, et al. Effects of Food Components That Activate TRPA1 Receptors on Mucosal Ion Transport in the Mouse Intestine. Nutrients. 2016;8(10):623. https://doi.org/10.3390/nu8100623
  39. Gazak R, Walterova D, Kren V. Silybin and silymarin – new and emerging applications in medicine. Curr Med Chem. 2007;14(3):315-338. https://doi.org/10.2174/092986707779941159
  40. Lim R, Morwood CJ, Barker G, Lappas M. Effect of silibinin in reducing inflammatory pathways in in vitro and in vivo models of infection-induced preterm birth. PLoS One. 2014;9(3):e92505. https://doi.org/10.1371/journal.pone.0092505
  41. Do Nascimento RF, de Oliveira Formiga R, Machado FDF, et al. Rosmarinic acid prevents gastric ulcers via sulfhydryl groups reinforcement, antioxidant and immunomodulatory effects. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(12):2265-2278. https://doi.org/10.1007/s00210-020-01894-2
  42. Yi D, Liu X, Wang M, et al. Rosmarinic acid alleviated intestinal barrier damage caused by Escherichia coli by regulating the gut microbiota and inhibiting the NF-κB signalling pathway in mice. Food Funct. 2024;15(23):11740-11756. https://doi.org/10.1039/d4fo02654c
  43. Li K, Wu J, Xu S, Li X, Zhang Y, Gao X-j. Rosmarinic acid alleviates intestinal inflammatory damage and inhibits endoplasmic reticulum stress and smooth muscle contraction abnormalities in intestinal tissues by regulating gut microbiota. Microbiol Spectr. 2023;11(5):e0191423. https://doi.org/10.1128/spectrum.01914-23
  44. Громова О.А., Торшин И.Ю., Тетруашвили Н.К. Систематический обзор экспериментальных и клинических исследований по фармакологии глицирризина и его производных. Акушерство и Гинекология. 2022;4:34-46. https://doi.org/10.18565/aig.2022.4.34-46
  45. Cheng B, Dong Y, Li X, et al. Glycyrrhizic acid inhibited inflammatory response in LPS-stimulated microglial BV2 cells via MAPK, Akt and NF-κB signaling pathways. Pharmazie. 2025;80(4):55-59. https://doi.org/10.1691/ph.2025.5532
  46. Germann I, Hagelauer D, Kelber O, et al. Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast) Phytomedicine. 2006;13(5):45-50. https://doi.org/10.1016/j.phymed.2006.03.018
  47. Michael S, Kelber O, Hauschildt S, Spanel-Borowski K, Nieber K. Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6. Phytomedicine. 2009;16:161-171. https://doi.org/10.1016/j.phymed.2008.10.011
  48. Michael S, Abdel-Aziz H, Weiser D, Müller CE, Kelber O, Nieber K. Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast) in rat small intestinal preparations. Naunyn Schmiedebergs Arch Pharmacol. 2012;385:411-421. https://doi.org/10.1007/s00210-011-0714-y
  49. Hohenester B, Rühl A, Kelber O, Schemann M. The herbal preparation STW5 (lberogast) has potent and region-specific effects on gastric motility. Neurogastroenterol Motil. 2004;16(6):765-773. https://doi.org/10.1111/j.1365-2982.2004.00548.x
  50. Ammon HP, Kelber O, Okpanyi SN. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. Phytomedicine. 2006;13:67-74. https://doi.org/10.1016/j.phymed.2006.08.004
  51. Khayyal MT, Seif-El-Nasr M, El-Ghazaly MA, Okpanyi SN, Kelber O, Weiser D. Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity. Phytomedicine. 2006;13(5):56-66. https://doi.org/10.1016/j.phymed.2006.03.019
  52. Ивашкин В.Т., Маев И.В., Шептулин А.А. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению функциональной диспепсии. Рос журн гастроэнтерол гепатол колопроктол. 2017;27(1):50-61. https://doi.org/10.22416/1382-4376-2017-27-1-50-6
  53. Синдром раздраженного кишечника : рубрикатор клинических рекомендаций / Министерство здравоохранения Российской Федерации. – Текст : электронный. – 2024. – ID: 892_1 (дата обращения: 03.08.2026). https://cr.minzdrav.gov.ru/view-cr/892_1
  54. Ottillinger B, Storr M, Malfertheiner P, Allescher HD. STW 5 (Iberogast) – a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr. 2013;163(3-4):65-72. https://doi.org/10.1007/s10354-012-0169-x
  55. Möller J, et al. STW 5 in 1515 patients with functional gastrointestinal diseases [conference abstract]. Planta Med. 2019;85(18):P-422. https://doi.org/10.1055/s-0039-3400131
  56. Michael R, Bettina V, Eckehard L. Functional gastrointestinal disorders in children: Effectivity, safety, and tolerability of the herbal preparation STW-5 (Iberogast) in general practice. Complement Ther Med. 2022;71:102873. https://doi.org/10.1016/j.ctim.2022.102873
  57. Raedsch R, Vinson B, Ottillinger B, Holtmann G. Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders. Wien Med Wochenschr. 2018;168(3-4):89-98. https://doi.org/10.1007/s10354-017-0578-y
  58. Törnblom H, Carbone F, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology. 2026;170(6):1240-1260. https://doi.org/10.1053/j.gastro.2026.01.038
  59. Storr M, Andresen V, Frieling T, et al. S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut-Brain Interaction (DGBI) [English Language Edition]. Gastroenterol Res Pract. 2026;2026:2610765. https://doi.org/10.1155/grp/2610765
slide-cover
slide-cover
slide-cover
slide-cover
slide-cover
slide-cover
Издательство «Медиа Сфера»
РекламаДоставка/ОплатаО насКонтактыОбучение для редакцийПолитика конфиденциальностиПолитика обработки персональных данныхПубличная оферта на реализацию издательской продукции
ЖурналыПодпискаАрхивКнигиПроекты
  • RuStore

© 1998-2026

  • Телефоны издательства:

  • +7 (495) 482-41-18
  • +7 (495) 482-43-29

  • Прямой телефон отдела подписки
    (только по вопросам заказов и доставки журналов)

  • +7 (800) 250-18-12

  • пн-пт с 10:00 до 18:00

  • Telegram
  • VK
info@mediasphera.ru

  • Почтовый адрес:

  • Издательство «Медиа Сфера»,
    а/я 54, Москва, Россия, 127238

  • RuStore

© 1998-2026